Paul Sagan, Director at Moderna, Inc. (MRNA), sold 2,250 shares at $314.90 ($709K) on 2021-10-13, disclosed to the SEC on 2021-10-15.
Open-market sale of $709k MRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKAM | SELL | 2018-11-09 | $7.8M | — | Filing → |
| AKAM | SELL | 2018-08-08 | $5.9M | — | Filing → |
| AKAM | SELL | 2018-07-26 | $3.1M | — | Filing → |